• HotStart Universal 2X Green qPCR Master Mix Workflow

  2026-08-14

  Build a reproducible dye-based qPCR workflow for fusion-transcript studies, including FGFR2-AHCYL1 assays inspired by recent cholangiocarcinoma research. The guide combines practical setup parameters, melt-curve specificity checks, normalization strategies, and troubleshooting for dependable gene expression quantification.

• A-1210477 MCL-1 Apoptosis Workflow

  2026-08-14

  A-1210477 is a selective MCL-1 inhibitor for testing how MCL-1-dependent cancer cells resist mitochondrial apoptosis. This practical guide covers compound handling, dose-response design, BAX/BAK-aware validation, combination studies, and troubleshooting while keeping its in vitro scope distinct from in vivo claims.

• SAN-Plexus Assembloids Model Pacemaker Maturation

  2026-08-13

  This study develops human pluripotent stem cell-derived assembloids that combine sinoatrial node, cardiac ganglionated plexus, and atrial-like organoids to model neural regulation of pacemaker maturation. By integrating electrophysiology with human SAN spatial transcriptomics, the authors identify a prosaposin–GPR37 signaling program linking cardiac neurons to pacemaker-cell development and conduction function.

• ECL Western Blotting Substrate: Practical Guide

  2026-08-13

  ECL Western Blotting Substrate (SKU K2187) is a luminol-based, nonradioactive horseradish peroxidase detection reagent for chemiluminescent Western blot assays. It is intended for HRP-labeled immunoblots and film or CCD imaging, not for fluorescent or radioisotopic detection workflows.

• ABT-263: From Apoptosis to Senescence Biology

  2026-08-12

  ABT-263 (Navitoclax) is more than a Bcl-2-family inhibitor: it is a translational probe for testing how mitochondrial survival dependence shapes apoptosis, senescence, fibrosis, and therapeutic response across disease models.

• PP2A, Autophagy, and Candida Biofilm Resistance

  2026-08-12

  Shen et al. identify a mechanistic link between protein phosphatase 2A, autophagy-related protein phosphorylation, and drug resistance in Candida albicans biofilms. Their combination of PPH21 genetic disruption, rapamycin-mediated autophagy activation, and an oral infection model suggests that the PP2A–Atg13–Atg1 axis is a potential target for studying biofilm-associated antifungal failure.

• Annexin V-PE Reagent in CD38 CAR-T Assays

  2026-08-11

  Use Annexin V-PE Reagent to quantify phosphatidylserine externalization in CD38 CAR-T co-cultures, separating target-cell killing from possible effector-cell fratricide. The one-step, 15–30-minute workflow supports both flow cytometry and fluorescence microscopy for rapid apoptosis profiling during binder optimization.

• ABT-199 (Venetoclax) Workflow for Apoptosis Assays

  2026-08-11

  Build more informative apoptosis experiments with ABT-199 (Venetoclax), a selective BCL-2 probe for mapping mitochondrial dependence in lymphoma, AML, and senescence models. This practical guide combines dose-response design, time-resolved readouts, combination testing, and troubleshooting for more reproducible results.

• Resiniferatoxin (RTX): TRPV1 Analgesia

  2026-08-10

  Resiniferatoxin (RTX) is an ultra-potent TRPV1 agonist that converts selective channel activation into prolonged desensitization of pain-sensing afferents. Its research value spans neuropathic pain, osteoarthritis pain, neurogenic inflammation, and route-specific sensory-neuron studies.

• BCL-XL Inhibitor A-1155463: Research Workflows

  2026-08-09

  A practical guide to using A-1155463 for dependency mapping, apoptosis assays, resistance studies, and translational tumor models. The workflow emphasizes selective BCL-XL biology, exposure control, sequential treatment design, and platelet-aware interpretation.

• Methylprednisolone Workflows for Inflammation Models

  2026-08-08

  Methylprednisolone provides a controlled glucocorticoid challenge for macrophage, PBMC, skin, and bone research. This workflow connects receptor-driven anti-inflammatory assays with a quantified rat model of glucocorticoid-induced osteonecrosis and practical troubleshooting guidance.

• PDK4-IN-1 hydrochloride: Research Workflow

  2026-08-07

  Build stronger metabolism experiments with a selective pyruvate dehydrogenase kinase 4 inhibitor that connects PDH activation to mitochondrial respiration, glycolysis, and TCA-cycle flux. This guide combines practical cell and animal workflows with controls that distinguish pathway engagement from nonspecific toxicity.

• Redefining Translational Drug Discovery with FDA-Approved Li

  2026-08-07

  This article explores how the DiscoveryProbe™ FDA-approved Drug Library (SKU: L1021) empowers translational researchers to bridge mechanistic insights and therapeutic innovation. By integrating biological rationale, experimental validation, and competitive context, we examine the unique strategic value of leveraging a clinically-validated, mechanism-rich compound library for drug repositioning, target identification, and disease model interrogation—illustrated through applications in neurodevelopmental disorders and beyond.

• Pentoxifylline as a Phosphodiesterase Inhibitor in Research

  2026-08-06

  Pentoxifylline stands out as a versatile phosphodiesterase inhibitor with proven applications in inflammation, immune modulation, and assisted reproduction. This guide provides actionable protocols, troubleshooting strategies, and cross-domain insights that maximize reproducibility and scientific impact.

• AI-Driven Discovery of Senolytics: Methodology and Impact

  2026-08-06

  This article analyzes the recent Nature Communications study leveraging machine learning to identify new senolytic compounds. The work demonstrates how data-driven approaches enable cost-effective, scalable senolytic discovery and highlights implications for translational cancer and aging research.

16387 records 1/1093 page Next 12345 下5页 Last page